RONNIE JAMES DIO STAND UP AND SHOUT CANCER FUND UPDATE:
LOS ANGELES, Feb. 20, 2013 -- The Ronnie James Dio Stand Up and Shout Cancer Fund (Dio Cancer Fund) Board of Directors presented the T.J. Martell Foundation
with $100,000 during the 5th Annual Wine Celebration Dinner in Los
Angeles on Wednesday, February 6th. The contribution is part of a
three-year pledge for gastric cancer research at Vanderbilt-Ingram
Cancer Center.
Formed in honor of the legendary singer who lost his life to stomach
cancer, The Ronnie James Dio Stand Up and Shout Cancer Fund is a
501(c)(3) non-profit charitable fund dedicated to support prostate,
colon and stomach cancer research, raise awareness and educate the
public with the focus that early detection and prevention is of vital
importance when dealing with this deadly disease that robs families of
its loved ones.
Wendy Dio, President and Founder of the Cancer Fund, made the
check presentation to the T.J. Martell Foundation's CEO Laura Heatherly,
saying, "After my husband, Ronnie James Dio passed away from Gastric
Cancer, I made a promise to him to raise funds for cancer research and
education and I formed the Ronnie James Dio Stand Up and Shout Cancer
Fund. Two and a half years ago we pledged $300,000 to the T.J. Martell
Foundation and with our recent donation of $100,000 we have met our
pledge. We intend to continue to raise funds for cancer research and
hope one day we can find a cure for this horrible disease."
"We have a special partnership with Wendy Dio and the Board of Directors of the Ronnie James Dio Cancer Fund," said Laura Heatherly. "Both
groups are working hard to do what we can to fund important cancer
research that will eventually turn into drug discoveries and clinical
trials which ultimately may save someone's life."
With the support of the Ronnie James Dio Stand Up and Shout Cancer Fund,
Vanderbilt has established a collaborative research environment with
some of the leading gastric cancer researchers in the world including
Pelayo Correa, M.D., Richard Peek Jr., M.D., James R. Goldenring, M.D.,
Ph.D., Robert J. Coffey, M.D., Wael El-Rifai, M.D., Ph.D., and Stephen
Fesik, Ph.D. These key investigators have made seminal discoveries on
the causes of gastric cancer and are using these discoveries to find new
therapies.
Ven 22 Fév - 11:31